Stirling dad completes cross-country cycle ride for cancer charities
A Stirling dad who cycled more than 1,000 miles across the length of the UK for a special charity effort has said reaching the finish line was a 'life-changing' experience.
Ross Lang was part of a team of eight cyclists who have raised almost £50,000 for a pair of good causes after completing the 12-day trek from Land's End to John o'Groats.
They crossed the finish line last week, cheered on by family and friends - as well as the skirl of the pipes from the Wick RBLS Pipe Band.
After crossing the line, Ross admitted there were times where he wasn't sure about completing the gruelling pedal, but remembering the connection to the cause pushed him back into the saddle.
Ross said: 'It has been one of the best experiences of my life doing this ride.
'Cycling from Land's End to John O'Groats has always been an ambition, while raising so much money for Maggie's and Young Lives vs Cancer is just fantastic.
'It was tough going. Early on, I had a problem with my back, which I thought might stop me in my tracks, but the team's support and remembering why we were riding kept me going.'
Each rider had a deeply personal reason for taking on the challenge, having lost a wife, a parent or supported a loved one through cancer.
For Ross, 57, he was thinking about several people in his own life who have battled with cancer - including friends and partners - and in 2023, his stepfather passed away following a long battle with throat and lung cancer.
The Saltcoats-born dad was roared to the line by wife Jane and kids Ishbel and Dugald, as well as dog Jett.
Donations are still continuing to flood in above the £50,000 already raised - with the commitments set to be split equally between Maggie's, which offers practical and emotional support to people with cancer, and Young Lives vs Cancer which helps children and young people find strength as they fight the disease.
Ride Against Cancer organiser Jim Webster, co-founder of the architecture studio HAUS Collective, whose wife survived breast cancer, said: 'We took on this challenge to do something together that was positive after each of us had a loved one go through cancer and it's been both incredible and humbling.
'So many Scottish businesses stepped up to support us with logistics, supplies and donations and we've had an incredible team of helpers, including colleagues, friends and family.
'We know that cancer affects almost everyone at some point, but it really hit home during the ride as so many people stopped us after spotting our Ride Against Cancer jerseys to share their own stories.
'We're hugely grateful to everyone who's donated to help Maggie's and Young Lives vs Cancer be there for families when they need it most.'
To offer your support to the team's effort, you can still donate at givewheel.com/fundraising/6822/Ride-Against-Cancer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
an hour ago
- Daily Record
Terrifying new synthetic opioid 'pyro' linked to dozens of overdose deaths this year
Etonitazene, a superstrong lab-made substance, is contaminating street heroin and contributing to a new rise in Scottish drug deaths. A terrifying new drug dubbed 'pyro' has been linked to at least 28 overdose deaths this year, the Sunday Mail can reveal. Found in street heroin, etonitazene – which can be 800 times stronger than morphine – was detected in Scotland for the first time in December. Known by its street name, the lethal contaminant has been found in dozens of suspected drug fatalities. In has mostly been seen in heroin, where it is believed to have been used as a cutting agent, but it has also been found in Valium-type benzodiazapene pills. Addicts are believed to be unaware they are taking it in most cases – with reports of people overdosing almost instantly. The lab-made substance is a synthetic nitazene opioid similar to notorious drug fentanyl, which has ravaged the US, and is often hundreds of times stronger than heroin. One ex-drug user said he believes up to 90 per cent of heroin is being cut with deadly opioids like pyro and fentanyl. The Glasgow dad, in his 30s, who is currently in recovery, told the Sunday Mail: 'It's going completely under the radar. It's incredibly common across the whole UK for one place to get a strong batch then a bunch of folk die, the dealers go into hiding for a bit but no one ever knows because generally families don't want to talk about it. 'So the dealers get off scot free and return when things have calmed and the cycle repeats. 'The folk still using are sitting ducks. You can OD pretty easily, especially if your tolerance is low, or nod out straight away, but the feeling is so similar [to heroin] it's hard to tell the difference. 'Most folk would just think they've got something very pure, that's what makes it dangerous.' He told how a friend with an 'on-off' heroin habit narrowly survived an overdose from smoking a single hit. Public Health Scotland's (PHS) latest quarterly report on drug deaths, harms and trends was published on Tuesday. It was the first to include etonitazene in toxicology screenings. The drug was detected in a shocking 28 deaths from January to March. But experts believe this is an underestimate because of how quickly nitazenes leave the body. Intelligence supplied to PHS's Rapid Action Drug Alerts and Response (Radar) team reveal drugs like heroin, benzos and cocaine cut with suspected nitazenes from the central belt to the Highlands and the north-east. Professor Andrew McAuley, a drugs expert at Glasgow Caledonian University, said nitazenes are a 'minority feature' of the drugs market but added: 'They are attracting a lot of attention because the harm associated with those drugs is much more severe than it is with other street drugs. "We don't fully understand the breadth of nitazenes so we're not always on top of testing them. 'Etonitazene is a very good example of that as something that wasn't routinely tested for until very recently. It's difficult to know how long it's been around in the supply chain for. 'But something as strong as etonitazene, I think if it had been here in any significant volume we'd have known about in A&Es and mortuaries. 'Over the last couple of months as we've started to detect it in much more frequent volumes, you can see how quickly the harm indicators have shifted in relation to that. 'There has been a bit of a spike in naloxone administrations and a spike in drug-related deaths, all related to opioids.' He warned the spike may be because 'the people using them are now being exposed to these very toxic adulterants'. Reports suggest contaminated heroin sometimes has a 'red tinge' or is darker than usual, particularly when prepared for injection, but experts say colours and appearance vary. Join the Daily Record WhatsApp community! Get the latest news sent straight to your messages by joining our WhatsApp community today. You'll receive daily updates on breaking news as well as the top headlines across Scotland. No one will be able to see who is signed up and no one can send messages except the Daily Record team. All you have to do is click here if you're on mobile, select 'Join Community' and you're in! If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose 'exit group'. If you're curious, you can read our Privacy Notice. Nitazenes were detected in at least 170 drug deaths across Scotland since 2022. There were 312 suspected drug-related deaths between March and May, a rise of 15 per cent on the previous quarter. Radar's testing over the period found 58 per cent of street drugs did not contain purely the intended purchase substance. Six of 25 samples purchased as heroin were laced with etonitazene. McAuley said the ever-evolving drugs scene was like playing 'whack-a-mole' for policymakers fighting Scotland's drug death rate, which is the worst in Europe. He said it was 'frightening', adding: 'You might have somebody who is quite an experienced user overdose almost instantly, sometimes with the needle still in their arm. "That is squarely rooted to the toxicity and the strength of these drugs. And unfortunately the data does suggest they're becoming an increasing feature of the market.' The rise of synthetic opioids has seen calls for services where users can test drugs. But campaigner Annemarie Ward told the Sunday Mail last week the benefits of the facilities were 'unevidenced'. She said they shouldn't be green lit without much more investment in rehab services. Public Health Scotland's Radar team has received reports from addicts of the rising threat of contaminated heroin. A UK-wide study at the start of the year warned: 'Alert of heroin supplied adulterated with nitazenes in Scotland and England, with heroin being described as having a 'red tinge' and involving sudden collapse.' A report from Lanarkshire read: 'Two reports of heroin purchased from street dealers- turned black when prepared for injection and not transparent. 'Reported as having an 'exceptionally strong opioid effect' in people with a history of injecting drug use, with one batch resulting in overdose.' One from Glasgow said: 'Nitazene present in illicit benzos called blues, vallies or 'blue Valium' that are sold £10 a batch. 'Tested after person reported 'being floored' after taking three pills.' An entry from north-east Scotland said: 'Intel following increase in overdoses in area… rapid onset after smoking/injecting heroin. One death confirmed positive for a nitazene.' Testing of heroin samples in Perth 'that caused nausea and confusion' contained two types of nitazenes, including superstrong etonitazene, also known as 'pyro'. Another report from North Lanarkshire, stated: 'Multiple overdoses at the same location after smoking a 'crumb' or granule of nitazenes.'
Telegraph
13 hours ago
- Telegraph
Streeting should ‘channel Thatcher' and introduce prostate screening
Wes Streeting should 'channel Margaret Thatcher ' and introduce screening for prostate cancer without delay, one of the world's leading experts has said. Prof Jonathan Waxman, the founder of the charity Prostate Cancer UK, says the Health Secretary should learn from Thatcher's decision to introduce routine mammograms for women, which he said had saved 3,000 lives a year since they were introduced in 1988. The Telegraph has launched a campaign calling for the introduction of targeted screening for prostate cancer so those at high risk are automatically offered tests. Prostate Cancer UK has submitted evidence in favour of the policy to the UK National Screening Committee (UKNSC), which is currently considering the matter, with a decision expected later this year. Writing for The Telegraph, Prof Waxman said: 'There are interesting parallels between the prostate cancer and breast cancer screening stories. 'In the 1970s, before breast cancer screening was introduced by Government dictat, the medical consensus was, and, you have guessed it, that early diagnosis through screening mammography would not save lives. 'Mrs T, regardless of the medical consensus, waved her handbag at the doctors, ignored the consensus, and launched a screening programme for breast cancer. And the result? Screening mammography, together with treatment advances, has led to a massive improvement in survival from breast cancer. 'Before screening, just 65 per cent of patients with breast cancer survived and now over 80 per cent are cured as a result of early detection and better treatment. 'And how does this improvement manifest in the real world? Around 3,000 fewer women die each year in the UK from breast cancer than before the screening programme was introduced.' The emeritus professor at Imperial College London said Prostate Cancer UK led a consortium of men's health charities to collectively inform the committee on the importance of targeted screening for those at highest risk. But he said the NHS should act now so that GPs do far more to help men at risk of prostate cancer. He urged the NHS to rewrite its guidance so that family doctors are told to proactively start conversations with men about the PSA blood tests which can detect the disease. Current guidance says that men can ask for a test, though some GPs rebuff them. For younger men, including those with a family history of disease, offering a test is down to the clinical judgment of GPs about. In both cases, the onus is on patients to seek help in the first place, with many men including those with family histories of prostate cancer unaware they are at heightened risk of the disease. Prof Waxman said the NHS should rewrite its advice so that GPs are told that they should bring up prostate cancer with all patients who might be at extra risk. He added that the guidelines should suggest that GPs start conversations with men from the age of 45 at highest risk, so those who wish to can obtain a PSA test. 'This puts the power of informed choice back in the hands of men who need it the most and is a crucial step on the path to early diagnosis,' he says. In the past, screening advisers have rejected the practice on the grounds that the tests are too unreliable, and could result in too many men undergoing needless procedures. However, in recent years the back-up diagnostics used to confirm the initial test findings have significantly improved. A Department of Health and Social Care spokesman said: 'This Government has been clear we would like to see screening in place, but the decision must be evidence-led. 'The UK National Screening Committee is looking at this as a priority – including reviewing the evidence for screening men with a family history of prostate cancer. 'While the review is taking place we are getting on with improving cancer treatment and prevention, as well as funding tens of millions of pounds of research – GPs should consider risk factors and use clinical judgment when considering if patients need a prostate cancer test.' Prostate cancer is a lot more than a nuisance By Jonathan Waxman Sixty years ago, around 10,000 people in the UK were diagnosed annually with prostate cancer. Currently over 50,000 men are diagnosed each year and prostate cancer has the dreadful distinction of being the commonest cancer in men. In parallel, the number of prostate cancer deaths has increased from 3,300 to over 12,000 men annually. So, what to do? We can hope that the treatment of prostate cancer will improve and improve, and cures are found. Treatment is getting better. Thankfully, in 2025, well over 80 per cent of men with prostate cancer that has not spread beyond the prostate will be cured and the duration of survival for men with cancer that has spread has doubled compared with 25 years ago. These improvements have come because of modern medicine's marvellous miracles, developing from brilliant university research and big pharma's R & D. Prostate Cancer UK has invested over £120m in research over the years. But clearly despite the gloss of shiny medical breakthroughs, prostate cancer remains a fundamentally unpleasant problem, and a lot more than a nuisance. What can be done? Find it early, you say? Yes, that would seem logical. How do we do this? Well, if we want to find prostate cancer early then the obvious answer is to screen for prostate cancer. There is no UK screening programme for the early detection of prostate cancer, a cancer which is often without symptoms. The National Screening Committee is currently considering the role of screening for prostate cancer. Prostate Cancer UK has led a consortium of men's health charities to collectively inform the committee, which advises government, on the importance of targeted screening for those at highest risk. There are interesting parallels between the prostate cancer and breast cancer screening stories. In the 1970s, before breast cancer screening was introduced by Government dictat, the medical consensus was, and, you have guessed it, that early diagnosis through screening mammography would not save lives. Mrs T, regardless of the medical consensus, waved her handbag at the doctors, ignored the consensus, and launched a screening programme for breast cancer. And the result? Screening mammography together with treatment advances have led to a massive improvement in survival from breast cancer. Before screening, just 65 per cent of patients with breast cancer survived and now over 80 per cent are cured as a result of early detection and better treatment. And how does this improvement manifest in the real world? Around 3000 fewer women die in the UK from breast cancer each year than before the screening programme was introduced. To return to the debate on screening for prostate cancer. We are now at a critical inflection point in the history of prostate cancer screening. Last year, Prostate Cancer UK published research that showed prostate cancer diagnosis is safer and more accurate than ever before, and this in part is thanks to research the charity funded leading to MRI – Magnetic Resonance Imaging – being introduced into the diagnostic pathway. The National Screening Committee, under the iron baton of its excellent chair, is currently deliberating on the evidence for and against screening for prostate cancer and will issue a report this year. In heavily trailed remarks, Wes Streeting has indicated that he is in favour of screening but not for everyone, just for selective high risk groups of men. We at Prostate Cancer UK welcome this ministerial support, for it is also our view that there is a need for screening, and we believe the evidence is now there for targeted screening. We welcome his remarks at a time when we are about to launch TRANSFORM, a multi-centre screening trial using sophisticated technologies based on current diagnostic tools, an adaptive trial that is open to new screening tests. Prostate Cancer UK's trial invests £42m in a very long-term campaign to assess the survival benefits of modern screening methods. So, who are Mr Streeting's selective high risk groups of men at increased risk of prostate cancer? These are men with family histories of prostate cancer who constitute 1 to 5 per cent of all diagnosed patients, and black men, who have a one in four risk of prostate cancer, which is twice the risk of white men. What to do whilst we await the Screening Committee's conclusions? Currently GP guidelines concerning testing for prostate cancer are outdated. We urgently need these NHS guidelines updated to empower GPs to proactively start conversations about PSA testing with men from the age of 45 at highest risk. This puts the power of informed choice back in the hands of men who need it the most and is a crucial step on the path to early diagnosis. So, yes, prostate cancer is a bit of a nuisance, but let us see if we can do something about that nuisance. Prof Jonathan Waxman OBE is the founder and president of Prostate Cancer UK
Daily Mail
14 hours ago
- Daily Mail
Sir Chris Hoy explains why he feels 'lucky' after cancer diagnosis granted him 'the time to really appreciate life'
Sir Chris Hoy says his terminal cancer diagnosis has given him something many others never get: time to reflect, reset priorities and truly appreciate life. The Olympic legend, who revealed in October that he has stage four prostate cancer, has become a powerful voice for early detection and a living example that serious illness need not mean the end of meaningful living. Speaking to The Telegraph, Hoy reflected on friends who died suddenly, without the chance to say goodbye. He said: 'What would they have given for that? And therefore, for me, I think: "Well, aren't I lucky?" Look at the privilege I've got, the time to really appreciate life.' Hoy had no symptoms before his diagnosis. Then a sore shoulder led to a scan, which revealed a tumour. Further tests confirmed the cancer had spread to his bones. He was 47. Since then, Hoy, now 49, has thrown himself into raising awareness — particularly for men over 45 or those with risk factors like a family history. His own father was diagnosed with prostate cancer shortly before the London 2012 Olympics, but made a full recovery thanks to early detection. Hoy has also seen the impact of speaking out. NHS data shows a sharp rise in urological cancer referrals since his announcement, while Prostate Cancer UK has reported a major spike in risk assessments among men. He's not one to seek praise — in fact, he draws inspiration from others who spoke publicly about their diagnoses, including Rob Burrow and Doddie Weir. 'They stood up and they smiled and they used humour and they recognised that they could make a difference. I don't really see myself in the same vein as those two, but if I could have any impact at all…' Hoy is currently training for his September event, the Tour de 4, a mass-participation charity ride with routes for all abilities. He'll be tackling the toughest 56-mile route and says the goal is to challenge public perceptions of what living with stage four cancer can look like. He's also clear-eyed about the emotional toll of his diagnosis — including the fear, panic and difficult conversations with his children. But he credits his family, his support network, and the simple power of staying in the present for getting him through. 'It's the fear of the future that causes anxiety and stress for most people,' he said. 'So it's not allowing yourself to fast forward and try and predict what's going to happen because you never know.' Hoy's wife Sarra was diagnosed with multiple sclerosis just weeks after his own news. The couple have faced both challenges side by side, and Sarra is now training for Tour de 4 too. Between workouts, Hoy has returned to motor racing, recently driving at Le Mans with Top Gear's Chris Harris. But he insists the everyday moments matter most — time with his children, a good film, a shared laugh. He hopes his public platform will help others facing cancer feel less alone, and inspire men to get checked before it's too late. 'If my legacy is that less men are dying from prostate cancer, that would be incredible,' he concluded.
